Bioventus Inc.
BVS
$9.15
-$0.36-3.79%
| 12/31/2024 | 09/28/2024 | 06/29/2024 | 03/30/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 41.58M | 43.07M | 31.99M | 25.17M | 36.96M |
| Total Receivables | 127.47M | 121.93M | 137.31M | 125.54M | 123.05M |
| Inventory | 92.48M | 90.03M | 87.61M | 97.01M | 91.33M |
| Prepaid Expenses | 14.08M | 16.92M | 23.57M | 18.18M | 16.66M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 26.73M | 28.41M | -- | -- |
| Total Current Assets | 275.61M | 298.69M | 308.88M | 265.90M | 268.00M |
|
|
|||||
| Total Current Assets | 275.61M | 298.69M | 308.88M | 265.90M | 268.00M |
| Net Property, Plant & Equipment | 33.52M | 39.20M | 42.30M | 46.99M | 49.96M |
| Long-term Investments | 7.46M | 7.46M | 7.46M | 7.46M | 7.46M |
| Goodwill | 7.46M | 7.46M | 7.46M | 7.46M | 7.46M |
| Total Other Intangibles | 404.73M | 414.81M | 424.55M | 470.67M | 482.35M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.75M | 7.40M | 6.88M | -- | -- |
| Total Assets | 727.96M | 769.49M | 792.17M | 794.24M | 810.91M |
|
|
|||||
| Total Accounts Payable | 23.69M | 16.85M | 24.44M | 19.10M | 23.04M |
| Total Accrued Expenses | 65.61M | 54.24M | 49.01M | 158.30M | 55.45M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 31.26M | 42.48M | 42.40M | 76.43M | 32.66M |
| Total Finance Division Other Current Liabilities | 89.85M | 97.92M | 115.62M | 73.71M | 64.34M |
| Total Other Current Liabilities | 89.85M | 97.92M | 115.62M | 73.71M | 64.34M |
| Total Current Liabilities | 210.40M | 211.49M | 231.46M | 173.32M | 175.50M |
|
|
|||||
| Total Current Liabilities | 210.40M | 211.49M | 231.46M | 173.32M | 175.50M |
| Long-Term Debt | 308.29M | 345.02M | 344.72M | 355.43M | 367.00M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 16.51M | 17.57M | 18.45M | 19.86M | 20.96M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 7.16M | 8.58M | 8.48M | 76.26M | 26.34M |
| Total Liabilities | 542.35M | 582.66M | 603.11M | 576.81M | 589.79M |
|
|
|||||
| Common Stock & APIC | 505.59M | 503.22M | 501.05M | 497.06M | 494.33M |
| Retained Earnings | -355.08M | -354.92M | -350.10M | -326.11M | -321.54M |
| Treasury Stock & Other | -2.57M | 445.00K | -17.00K | 325.00K | 794.00K |
| Total Common Equity | 147.94M | 148.74M | 150.94M | 171.28M | 173.59M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 147.94M | 148.74M | 150.94M | 171.28M | 173.59M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 37.66M | 38.10M | 38.13M | 46.16M | 47.53M |
| Total Equity | 185.60M | 186.83M | 189.06M | 217.43M | 221.12M |
|
|
|||||
